Search all trials

Find therapies in clinical trials near you – page 12

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Myelofibrosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Aprepitant

Contact Research Centre

Small cell lung cancer limited stage

Not recruiting

Registered drug

Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Newly Diagnosed Limited-Stage Small Cell Lung Cancer

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Gastroenteropancreatic neuroendocrine tumour disease

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Lanreotide

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab with Drug Combination for Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Boserolimab

Contact Research Centre

Bladder cancer+2

Not recruiting

Registered drug

Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study to Test Pembrolizumab, MK-4830, and MK-0482 in Patients with Advanced Non-Small Cell Lung Cancer Who Have Not Received Prior Treatment

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Mk-0482

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Boserolimab, MK-0482, and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-(L)1 Therapy

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Boserolimab

Contact Research Centre

Hormone-refractory prostate cancer+1

Not recruiting

Registered drug

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Non-small cell lung cancer stage I+1

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Bladder cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Pembrolizumab and Lenvatinib with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Lenvatinib

Contact Research Centre

Find therapies in clinical trials near you – page 12

150 trials match your criteria

Myelofibrosis

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Small cell lung cancer limited stage

Study of Pembrolizumab and Olaparib with Chemoradiation for Patients with Newly Diagnosed Limited-Stage Small Cell Lung Cancer

Gastroenteropancreatic neuroendocrine tumour disease

Study on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Non-small cell lung cancer

Study of Pembrolizumab with Drug Combination for Patients with Advanced Non-Small Cell Lung Cancer

Bladder cancer+2

Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

Non-small cell lung cancer

Study to Test Pembrolizumab, MK-4830, and MK-0482 in Patients with Advanced Non-Small Cell Lung Cancer Who Have Not Received Prior Treatment

Non-small cell lung cancer

Study of Boserolimab, MK-0482, and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-(L)1 Therapy

Hormone-refractory prostate cancer+1

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Non-small cell lung cancer stage I+1

Study on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer

Breast cancer

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Bladder cancer

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Non-small cell lung cancer

Study Comparing Pembrolizumab and Lenvatinib with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.